Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience

por Gürsoy, Pınar, Çakar, Burcu, Ön, Sercan, Göker, Erdem, Nart, Deniz
Publicado 2022

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorourac...

por Curran, Desmond, Pozzo, Carmelo, Zaluski, Jerzy, Dank, Magdalena, Barone, Carlo, Valvere, Vahur, Yalcin, Suayib, Peschel, Christian, Wenczl, Miklós, Goker, Erdem, Bugat, Roland
Publicado 2009

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

por Goss, Glenwood D, Cobo, Manuel, Lu, Shun, Syrigos, Konstantinos, Lee, Ki Hyeong, Göker, Erdem, Georgoulias, Vassilis, Isla, Dolores, Morabito, Alessandro, Min, Young J, Ardizzoni, Andrea, Bender, Shaun, Cseh, Agnieszka, Felip, Enriqueta
Publicado 2021

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

por Akyildiz, Arif, Guven, Deniz Can, Ozluk, Ahmet Anil, Ismayilov, Rashad, Mutlu, Emel, Unal, Olcun Umit, Yildiz, Ibrahim, Iriagac, Yakup, Turhal, Serdar, Akbas, Sinem, Bayram, Ertugrul, Telli, Tugba Akin, Turkoz, Fatma Paksoy, Ozcelik, Melike, Erciyestepe, Mert, Selvi, Oguzhan, Gulbagci, Burcu, Erturk, Ismail, Isleyen, Zehra Sucuoglu, Kahraman, Seda, Akdag, Mutianur Ozkorkmaz, Hamitoglu, Buket, Unek, Ilkay Tugba, Unal, Caglar, Hacibekiroglu, İlhan, Arslan, Cagatay, Azizy, Abdulmunir, Helvaci, Kaan, Demirci, Umut, Dizdar, Omer, Basaran, Mert, Goker, Erdem, Sendur, Mehmet Ali, Yalcin, Suayib
Publicado 2023